If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
480.60    2.60 (0.54%)
Bid:
480.60
Ask:
481.60
Spread: 1.00 (0.208%)
Market Cap: £2.47b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

LTPA Extension

22 May 2025 07:01

RNS Number : 6880J
QinetiQ Group plc
22 May 2025
 

News release

QinetiQ Group plc

LTPA extension worth £1.54 billion to modernise test & evaluation for future warfare

22 May 2025 - QinetiQ Group plc ("QinetiQ") today announces a five-year, £1.54 billion extension to its Long Term Partnering Agreement (LTPA) with the UK's Ministry of Defence (MOD) that will transform the provision of mission critical test and evaluation capabilities and services that help to enhance operational readiness of the UK and allied nations.

Alongside the contract amendment extending the LTPA to 2033, the Company is also recognising an incremental order of £166 million relating to current investments in test and evaluation.

Through the LTPA, QinetiQ delivers vital Test, Trials, Training and Evaluation (T3E) capabilities that ensure armed forces personnel are equipped and prepared for mission success. Over the next eight years, QinetiQ and the MOD will continue to invest to deliver T3E for next generation defence technologies such as uncrewed systems, hypersonics and directed energy weapons. Digitalisation will increase the pace at which new concepts and solutions are tested and then delivered into service. QinetiQ and the MOD have committed to improve access for agile and innovative small and medium sized enterprises (SMEs) to use the LTPA's services.

Defence Secretary John Healey MP said: "Rigorously tested equipment and the trialling of emerging technologies are key to ensuring our armed forces are using combat-ready capabilities on the frontline.

"The contract will help keep Britain secure at home and strong abroad, as we drive forward innovation to bolster our national security and support skilled jobs across the UK.

"With hundreds of British businesses supported by this investment through QinetiQ's supply chain, we are demonstrating how defence is an engine for growth across the UK, and delivering on our Plan for Change."

Steve Wadey, Group Chief Executive Officer at QinetiQ, said: "Through the LTPA, we play a vital role helping to protect and enhance the UK's defence and security. The extension of our partnership with MOD enables us to continue investing to deliver the transformational change in test and evaluation that's required to ensure our armed forces have operational advantage over disruptive technologies.

"We're seeing increased demand for our services from NATO countries and this LTPA extension positions the UK as a leading centre for T3E and facilitates the delivery of major equipment platforms as well as future upgrade programmes."

The extension to the LTPA will sustain more than 1,200 highly skilled jobs at 16 MOD sites across England, Scotland and Wales and support an increasingly diverse supply chain of more than 825 companies across the UK, 590 of which are SMEs.

Earlier this month, QinetiQ hosted Formidable Shield, a NATO joint strike exercise, at the MOD Hebrides range - one of 16 sovereign sites managed under the LTPA.

Since the signing of the original 25-year contract in 2003, QinetiQ, in partnership with MOD, has delivered T3E services which have supported crucial moments in UK defence. These include the first launch of a ballistic rocket into space from the UK, the UK's first firing of a high-power laser directed energy weapon against aerial targets and Europe's first successful demonstration of teaming a piloted aircraft with an autonomous air vehicle. The extension will support the delivery of a range of future defence capability including the Global Combat Air Programme (GCAP), Dreadnought nuclear submarines as well as drones.

 

For further information, please contact:

Stephen Lamacraft, Group Interim Director Investor Relations: +44 (0) 7471 885817

Stephanie Mann, Group Head of Media Relations (Media enquiries): +44 (0) 7770 720268

 

About QinetiQ

 

QinetiQ is an integrated global defence and security company focused on mission-led innovation. Our purpose is protecting lives by serving the national security interests of our customers. We employ more than 8,500 highly-skilled people, committed to creating new ways of testing technologies, systems, and processes to make sure they meet operational needs, and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

Visit www.QinetiQ.com for more information, or follow us on LinkedIn.

About LTPA

The Long Term Partnering Agreement (LTPA) is a strategic framework contract originally signed in 2003, between QinetiQ and the UK Ministry of Defence, delivering Test, Trials, Training and Evaluation services through 16 core MOD-owned sites in England, Scotland and Wales.

 

Under the LTPA, QinetiQ supports the UK MOD - and its allies - in ensuring Land, Maritime and Air assets, as well as weapons capabilities, meet the frontline's requirements, through investment in new technology, facilities and operating models.

 

Visit www.t3e.uk for more information.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUAAARVNUVUUR
Date   Source Headline
1st Nov 202111:43 amRNSBlock listing Interim Review
19th Oct 20219:16 amRNSHolding(s) in Company
14th Oct 20217:00 amRNSTrading Update
12th Oct 202110:43 amRNSDirector/PDMR Shareholding
10th Sep 20212:07 pmRNSDirector/PDMR Shareholding
31st Aug 20212:35 pmRNSDirector/PDMR Shareholding
11th Aug 20219:07 amRNSDirector/PDMR Shareholding
27th Jul 202110:46 amRNSDirectorate Change
26th Jul 20214:33 pmRNSDirector/PDMR Shareholding
21st Jul 202110:55 amRNSResult of AGM
21st Jul 20217:00 amRNSFirst Quarter Trading Update
14th Jul 20218:47 amRNSChange of AGM venue
13th Jul 20219:52 amRNSHolding(s) in Company
12th Jul 202111:12 amRNSDirector/PDMR Shareholding
2nd Jul 20217:00 amRNSChief Financial Officer succession
29th Jun 20213:49 pmRNSDirector/PDMR Shareholding
15th Jun 202110:55 amRNSAnnual Financial Report
10th Jun 202111:15 amRNSDirector/PDMR Shareholding
9th Jun 20215:01 pmRNSDirector/PDMR Shareholding
1st Jun 20219:34 amRNSTotal Voting Rights
25th May 202110:54 amRNSBlock Listing Application
20th May 20217:00 amRNSPreliminary Results
11th May 20211:53 pmRNSDirector/PDMR Shareholding
27th Apr 20212:08 pmRNSDeath of Non-Executive Director, Ian Mason
15th Apr 20212:49 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSTrading Update
12th Apr 20212:00 pmRNSDirector/PDMR Shareholding
12th Apr 20218:32 amRNSHolding(s) in Company
10th Mar 202112:23 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSInvestor Seminar
16th Feb 20218:55 amRNSDirector Declaration
10th Feb 202111:32 amRNSDirector/PDMR Shareholding
8th Feb 20219:57 amRNSDirector/PDMR Shareholding
13th Jan 20217:00 amRNSThird Quarter Trading Update
12th Jan 20219:49 amRNSDirector/PDMR Shareholding
4th Jan 20217:00 amRNSQinetiQ wins £127m Typhoon contract through EDP
21st Dec 20204:44 pmRNSHolding(s) in Company
10th Dec 202010:28 amRNSDirector/PDMR Shareholding
3rd Dec 20201:00 pmRNSSale of OptaSense to Luna
24th Nov 20201:31 pmRNSDirector/PDMR Shareholding
20th Nov 202012:37 pmRNSDirector/PDMR Shareholding
20th Nov 202011:43 amRNSHolding(s) in Company
17th Nov 202011:16 amRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSInterim Results
10th Nov 202010:47 amRNSDirector/PDMR Shareholding
12th Oct 202010:09 amRNSDirector/PDMR Shareholding
5th Oct 20209:10 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSPre-close Trading update
21st Sep 20203:57 pmRNSDirectorate Change
10th Sep 202010:29 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.